BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

231 related articles for article (PubMed ID: 31109340)

  • 1. Pre-clinical evaluation of Minnelide as a therapy for acute myeloid leukemia.
    Giri B; Gupta VK; Yaffe B; Modi S; Roy P; Sethi V; Lavania SP; Vickers SM; Dudeja V; Banerjee S; Watts J; Saluja A
    J Transl Med; 2019 May; 17(1):163. PubMed ID: 31109340
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Minnelide Inhibits Androgen Dependent, Castration Resistant Prostate Cancer Growth by Decreasing Expression of Androgen Receptor Full Length and Splice Variants.
    Isharwal S; Modi S; Arora N; Uhlrich C; Giri B; Barlass U; Soubra A; Chugh R; Dehm SM; Dudeja V; Saluja A; Banerjee S; Konety B
    Prostate; 2017 May; 77(6):584-596. PubMed ID: 28144973
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Downregulation of Sp1 by Minnelide leads to decrease in HSP70 and decrease in tumor burden of gastric cancer.
    Arora N; Alsaied O; Dauer P; Majumder K; Modi S; Giri B; Dudeja V; Banerjee S; Von Hoff D; Saluja A
    PLoS One; 2017; 12(2):e0171827. PubMed ID: 28192510
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Triptolide abrogates growth of colon cancer and induces cell cycle arrest by inhibiting transcriptional activation of E2F.
    Oliveira A; Beyer G; Chugh R; Skube SJ; Majumder K; Banerjee S; Sangwan V; Li L; Dawra R; Subramanian S; Saluja A; Dudeja V
    Lab Invest; 2015 Jun; 95(6):648-659. PubMed ID: 25893635
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Minnelide Overcomes Oxaliplatin Resistance by Downregulating the DNA Repair Pathway in Pancreatic Cancer.
    Modi S; Kir D; Giri B; Majumder K; Arora N; Dudeja V; Banerjee S; Saluja AK
    J Gastrointest Surg; 2016 Jan; 20(1):13-23; discussion 23-4. PubMed ID: 26503259
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Low-dose triptolide enhances antitumor effect of JQ1 on acute myeloid leukemia through inhibiting RNA polymerase II in vitro and in vivo.
    Shi Y; Zhao H; Ye J; Li Z; Deng M; Zha J; Zhou Y; Zeng H; Lin Y; Pu X; Guo C; Song H; Qiu Y; Xu B
    Mol Carcinog; 2020 Sep; 59(9):1076-1087. PubMed ID: 32691884
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Triptolide enhances the tumoricidal activity of TRAIL against renal cell carcinoma.
    Brincks EL; Kucaba TA; James BR; Murphy KA; Schwertfeger KL; Sangwan V; Banerjee S; Saluja AK; Griffith TS
    FEBS J; 2015 Dec; 282(24):4747-4765. PubMed ID: 26426449
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Triptolide cooperates with chemotherapy to induce apoptosis in acute myeloid leukemia cells.
    Pigneux A; Mahon FX; Uhalde M; Jeanneteau M; Lacombe F; Milpied N; Reiffers J; Belloc F
    Exp Hematol; 2008 Dec; 36(12):1648-59. PubMed ID: 18922616
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Minnelide reduces tumor burden in preclinical models of osteosarcoma.
    Banerjee S; Thayanithy V; Sangwan V; Mackenzie TN; Saluja AK; Subramanian S
    Cancer Lett; 2013 Jul; 335(2):412-20. PubMed ID: 23499892
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MRx102, a triptolide derivative, has potent antileukemic activity in vitro and in a murine model of AML.
    Carter BZ; Mak DH; Shi Y; Fidler JM; Chen R; Ling X; Plunkett W; Andreeff M
    Leukemia; 2012 Mar; 26(3):443-50. PubMed ID: 21904380
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Combining triptolide with ABT-199 is effective against acute myeloid leukemia through reciprocal regulation of Bcl-2 family proteins and activation of the intrinsic apoptotic pathway.
    Shi YF; Liu L; He LL; Ye J; Lin ZJ; Yuan DL; Deng MM; Fang ZH; Carter BZ; Xu B
    Cell Death Dis; 2020 Jul; 11(7):555. PubMed ID: 32699295
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Triptolide induces caspase-dependent cell death mediated via the mitochondrial pathway in leukemic cells.
    Carter BZ; Mak DH; Schober WD; McQueen T; Harris D; Estrov Z; Evans RL; Andreeff M
    Blood; 2006 Jul; 108(2):630-7. PubMed ID: 16556893
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Triptolide sensitizes AML cells to TRAIL-induced apoptosis via decrease of XIAP and p53-mediated increase of DR5.
    Carter BZ; Mak DH; Schober WD; Dietrich MF; Pinilla C; Vassilev LT; Reed JC; Andreeff M
    Blood; 2008 Apr; 111(7):3742-50. PubMed ID: 18187663
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibition of epithelial ovarian cancer by Minnelide, a water-soluble pro-drug.
    Rivard C; Geller M; Schnettler E; Saluja M; Vogel RI; Saluja A; Ramakrishnan S
    Gynecol Oncol; 2014 Nov; 135(2):318-24. PubMed ID: 25172764
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Minnelide effectively eliminates CD133(+) side population in pancreatic cancer.
    Nomura A; McGinn O; Dudeja V; Sangwan V; Saluja AK; Banerjee S
    Mol Cancer; 2015 Nov; 14():200. PubMed ID: 26597727
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A preclinical evaluation of Minnelide as a therapeutic agent against pancreatic cancer.
    Chugh R; Sangwan V; Patil SP; Dudeja V; Dawra RK; Banerjee S; Schumacher RJ; Blazar BR; Georg GI; Vickers SM; Saluja AK
    Sci Transl Med; 2012 Oct; 4(156):156ra139. PubMed ID: 23076356
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Discovery of a novel water-soluble, rapid-release triptolide prodrug with improved drug-like properties and high efficacy in human acute myeloid leukemia.
    Kang D; Pan X; Song Y; Liu Y; Wang D; Zhu X; Wang J; Hu L
    Eur J Med Chem; 2022 Dec; 243():114694. PubMed ID: 36115206
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Primary and liver metastasis-derived cell lines from KrasG12D; Trp53R172H; Pdx-1 Cre animals undergo apoptosis in response to triptolide.
    Sangwan V; Banerjee S; Jensen KM; Chen Z; Chugh R; Dudeja V; Vickers SM; Saluja AK
    Pancreas; 2015 May; 44(4):583-9. PubMed ID: 25875797
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impaired Synthesis of Stromal Components in Response to Minnelide Improves Vascular Function, Drug Delivery, and Survival in Pancreatic Cancer.
    Banerjee S; Modi S; McGinn O; Zhao X; Dudeja V; Ramakrishnan S; Saluja AK
    Clin Cancer Res; 2016 Jan; 22(2):415-25. PubMed ID: 26405195
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Minnelide suppresses GVHD and enhances survival while maintaining GVT responses.
    Copsel SN; Garrido VT; Barreras H; Bader CS; Pfeiffer B; Mateo-Victoriano B; Wolf D; Gallardo M; Paczesny S; Komanduri KV; Benjamin CL; Villarino AV; Saluja AK; Levy RB
    JCI Insight; 2024 Apr; 9(9):. PubMed ID: 38602775
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.